Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Fimasartan/Atorvastatin FDC vs Co-administration
NCT02994745Phase 1Completed
- Sponsor
- Boryung
- Start
- Dec 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fimasartan and atorvastatin in hypertension (HTN) and hyperlipidemia (3 arms), sponsored by Boryung. Primary endpoints: Maximum concentration of drug in plasma and Area under the plasma drug concentration-time curve from 0 to last quantifiable concentration. Started Dec 2016; status: completed.
02
Drugs
fimasartanatorvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT02994745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02994745.